Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Animals (Basel) ; 14(2)2024 Jan 05.
Article in English | MEDLINE | ID: mdl-38254356

ABSTRACT

Muscle atrophy and weakness are prevalent and debilitating conditions in dogs that cannot be reliably prevented or treated by current approaches. In non-canine species, the natural dietary compound ursolic acid inhibits molecular mechanisms of muscle atrophy, leading to improvements in muscle health. To begin to translate ursolic acid to canine health, we developed a novel ursolic acid dietary supplement for dogs and confirmed its safety and tolerability in dogs. We then conducted a randomized, placebo-controlled, proof-of-concept efficacy study in older beagles with age-related muscle atrophy, also known as sarcopenia. Animals received placebo or ursolic acid dietary supplements once a day for 60 days. To assess the study's primary outcome, we biopsied the quadriceps muscle and quantified atrophy-associated mRNA expression. Additionally, to determine whether the molecular effects of ursolic acid might have functional correlates consistent with improvements in muscle health, we assessed secondary outcomes of exercise participation and T-maze performance. Importantly, in canine skeletal muscle, ursolic acid inhibited numerous mRNA expression changes that are known to promote muscle atrophy and weakness. Furthermore, ursolic acid significantly improved exercise participation and T-maze performance. These findings identify ursolic acid as a natural dietary compound that inhibits molecular mechanisms of muscle atrophy and improves functional performance in dogs.

2.
Bioinspir Biomim ; 15(5): 056014, 2020 08 12.
Article in English | MEDLINE | ID: mdl-32554875

ABSTRACT

The ventral scales of most snakes feature micron-sized fibril structures with nanoscale steps oriented towards the snake's tail. We examined these structures by microtribometry as well as atomic force microscopy (AFM) and observed that the nanoscale steps of the micro-fibrils cause a frictional anisotropy, which varies along the snake's body in dependence of the height of the nanoscale steps. A significant frictional behavior is detected when a sharp AFM tip scans the nanoscale steps up or down. Larger friction peaks appear during upward scans (tail to head direction), while considerably lower peaks are observed for downward scans (head to tail direction). This effect causes a frictional anisotropy on the nanoscale, i.e. friction along the head to tail direction is lower than in the opposite direction. The overall effect increases linearly with the step height of the micro-fibrils. Although the step heights are different for each snake, the general step height distribution along the body of the examined snakes follows a common pattern. The frictional anisotropy, induced by the step height distribution, is largest close to the tail, intermediate in the middle, and lower close to the head. This common distribution of frictional anisotropy suggests that snakes even optimized nanoscale features like the height of micro-fibrils through evolution in order to achieve optimal friction performance for locomotion. Finally, ventral snake scales are replicated by imprinting their micro-fibril structures into a polymer. As the natural prototype, the artificial surface exhibits frictional anisotropy in dependence of the respective step height. This feature is of high interest for the design of tribological surfaces with artificial frictional anisotropy.


Subject(s)
Anisotropy , Friction/physiology , Skin/anatomy & histology , Snakes/anatomy & histology , Torso/anatomy & histology , Animals , Biomechanical Phenomena , Locomotion/physiology , Microscopy, Atomic Force , Skin/diagnostic imaging , Snakes/physiology , Species Specificity , Surface Properties , Torso/physiology
3.
J Chem Ecol ; 43(6): 563-572, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28647839

ABSTRACT

Reproduction in social insect societies reflects a delicate balance between cooperation and conflict over offspring production, and worker reproduction is widespread even in species showing strong reproductive skew in favor of the queen. To navigate these conflicts, workers are predicted to develop the means to estimate the queen's fecundity - potentially through behavioral and/or chemical cues - and to adjust their reproduction to maximize their fitness. Here, we introduced bumble bee, Bombus impatiens, workers to queens of different mating and reproductive status and examined worker reproduction and expression levels of two genes which were previously shown to be sensitive to the presence of the queen, vitellogenin and Krüppel-homolog 1. We further explored whether the queen's chemical secretion alone is sufficient to regulate worker reproduction, aggression and gene expression. We found that worker ovary activation was inhibited only in the presence of egg-laying queens, regardless of their mating status. Workers reared in the presence of newly-mated queens showed intermediate vitellogenin expression levels relative to workers reared with mated egg-laying and virgin queens. However, none of the whole-body chemical extracts of any of the queen treatment groups affected ovary activation, aggressive behavior, or gene expression in workers. Our findings indicate that only the presence of a freely-behaving, egg-laying queen can fully inhibit worker reproduction. It remains to be determined if workers detect differences in queen mating status and fecundity through differences in the queens' behavior alone or through the queen's behavior in concert with fertility signals.


Subject(s)
Bees/chemistry , Bees/physiology , Oviposition , Aggression , Animals , Behavior, Animal , Female , Fertility , Gas Chromatography-Mass Spectrometry , Gene Expression , Kruppel-Like Transcription Factors/genetics , Male , Ovary/chemistry , Ovary/metabolism , Reproduction , Sex Attractants/chemistry , Sex Attractants/metabolism , Vitellogenins/genetics , Vitellogenins/metabolism , Volatile Organic Compounds/chemistry , Volatile Organic Compounds/metabolism
4.
Vet Immunol Immunopathol ; 158(3-4): 199-207, 2014 Apr 15.
Article in English | MEDLINE | ID: mdl-24560650

ABSTRACT

Canine leishmaniasis, an important zoonotic disease of dogs, is the result of an ineffective and inappropriate immune response to infection with Leishmania infantum. It is widely accepted that the appropriate immune response is characterised by a T-helper (Th)1-dominated profile in an overall mixed Th1/Th2 response. The absence of a strong Th1 response is associated with progression to the clinical disease. Thus, there is a need for an effective vaccine that could modulate the immune response to a more appropriate profile against the parasite. In this study we measured the impact of the LiESP/QA-21 canine vaccine, recently launched commercially in Europe, on selected humoral and cellular immune markers for one year after a primary vaccination course. The humoral response to vaccination was characterised by a predominantly IgG2 profile. Vaccinated dogs developed long-lasting cell-mediated immune responses against L. infantum, specifically with a stronger ability of macrophages to reduce intracellular parasite burdens in co-culture with autologous lymphocytes compared to control dogs (p=0.0002), which was correlated with induction of inducible nitric oxide synthase (iNOS) and production of nitric oxide (NO) derivatives. These results confirm that vaccination with LiESP/QA-21 is capable of inducing an appropriate Th1-dominated immune profile which persists for a full year.


Subject(s)
Dog Diseases/prevention & control , Leishmania infantum/immunology , Leishmaniasis Vaccines/administration & dosage , Leishmaniasis, Visceral/veterinary , Animals , Antibodies, Protozoan/biosynthesis , Dog Diseases/immunology , Dogs , Female , Immunity, Cellular , Immunity, Humoral , Immunoglobulin G/biosynthesis , Leishmaniasis, Visceral/immunology , Leishmaniasis, Visceral/prevention & control , Male , Th1 Cells/immunology , Time Factors , Vaccination/veterinary , Zoonoses/immunology , Zoonoses/prevention & control
5.
Vet Microbiol ; 108(1-2): 113-8, 2005 Jun 15.
Article in English | MEDLINE | ID: mdl-15917139

ABSTRACT

Prevention of urinary shedding of Leptospira interrogans spp. by chronically infected dogs remains a key objective of the vaccination in dogs against leptospirosis which is a zoonotic disease. An inactivated bivalent vaccine composed of Leptospira interrogans serovars icterohaemorrhagiae [L. icterohaemorrhagiae] and canicola [L. canicola] bacterins was tested for its ability to protect puppies against a challenge exposure with L. icterohaemorrhagiae. The vaccine was administered twice at a 3-week interval to six puppies aged from 8 to 9 weeks. Six other puppies were used as unvaccinated controls. All puppies were challenged 2 weeks after the second vaccine injection by intraperitoneal (IP) administration of L. icterohaemorrhagiae (day 0). Clinical signs, haematological and biochemical changes and evidence of Leptospira in blood, urine and kidney were monitored for 4 weeks after the challenge exposure (days 0-28). Puppies were euthanised on day 28 for post-mortem and histological examinations of liver and kidney. Control group presented clinical pictures of severe or subclinical infection. One dog developed severe clinical signs (hypothermia, depression, anorexia, abdominal pain, dehydration, icterus, weight loss) and died on post-infection day (PID) 7 due to an acute renal failure. Gross and microscopic lesions were in accordance with this clinical pattern. In the five remaining control dogs, the challenge exposure induced mainly a systemic infection including leptospiraemia, leptospiruria and renal carriage. The vaccinated group remained healthy throughout the study period. In conclusion, immunisation with a Leptospira vaccine was shown to protect dogs against symptomatology and leptospiraemia, urine shedding and renal infection.


Subject(s)
Bacterial Vaccines , Dog Diseases/prevention & control , Kidney Diseases/veterinary , Leptospirosis/veterinary , Animals , Antibodies, Bacterial/blood , Dogs , Kidney Diseases/microbiology , Kidney Diseases/prevention & control , Leptospira interrogans/immunology , Leptospirosis/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...